Loading patent…
AssigneeNew Cancer Cure-Bio Co., Ltd.
InventorSoo Youl KIM
Estimating the term…
The present invention relates to a pharmaceutical composition for the prevention or treatment of cancer, including carnitine acylcarnitine carrier (CAC) inhibitor and an anticancer agent. The compositions comprising the carnitine acylcarnitine carrier inhibitor and the anticancer agent of the present invention not only significantly reduced the growth of various cancer cells compared to the use of the carnitine acylcarnitine carrier inhibitor or the anticancer agent alone, but also confirmed the anti-cancer synergistic effect of co-administration of the carnitine acylcarnitine carrier inhibitor and the anticancer agent in a xenograft tumor animal model. Thus, the composition of the present invention is useful as effective combination anticancer agent.
A pharmaceutical composition for the prevention or treatment of cancer, comprising a Carnitine Acylcarnitine Carrier (CAC) inhibitor and an anticancer agent as active ingredients.
An anti-cancer adjuvant comprising a Carnitine Acylcarnitine Carrier (CAC) inhibitor and an anti-cancer agent as active ingredients.
A method for preventing or treating of cancer, comprising administering a Carnitine Acylcarnitine Carrier (CAC) inhibitor and an anticancer agent as active ingredients to a subject in need thereof.
Dependencies are inferred from the claim text.